D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-2-methylphenyl]-, (1S)-

2161394-95-0

CAS-Nr.: 2161394-95-0

Englisch Name:: D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-2-methylphenyl]-, (1S)-

Synonyma:: Canagliflozin 2-Methylphenyl;(2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-2-methylphenyl)-6-(hydroxymethyl)tet;(2S,3R,4R,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-2-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

CBNumber:: CB78093173

Summenformel:: C24H25FO5S

Molgewicht:: 444.52

MOL-Datei:: 2161394-95-0.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 2

D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-2-methylphenyl]-, (1S)- Eigenschaften

Siedepunkt:: 643.4±55.0 °C(Predicted)

Dichte: 1.364±0.06 g/cm3(Predicted)

pka: 13.34±0.70(Predicted)

Sicherheit

D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-2-methylphenyl]-, (1S)- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Canagliflozin 2-Methylphenyl is an impurity of Canagliflozin (C175190). Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.

D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-2-methylphenyl]-, (1S)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-2-methylphenyl]-, (1S)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Pharmaffiliates Analytics and Synthetics P. Ltd	--	mktg@pharmaffiliates.com	India	6739	58
CLEARSYNTH LABS LTD.	--	sales@clearsynth.com	India	6257	58

Canagliflozin 2-Methylphenyl
(2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-2-methylphenyl)-6-(hydroxymethyl)tet
(2S,3R,4R,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-2-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
2161394-95-0